loading page

Post-Viral Olfactory Loss: A Survey of One Hundred and Twenty Patient Experiences
  • Thumbnail
  • Carl PhilpottOrcid,
  • James Boardman,
  • Duncan Boak
Carl Philpott
Orcid
University of East Anglia
Author Profile
Medium
James Boardman
Fifth Sense
Author Profile
Duncan Boak
Fifth Sense
Author Profile

Peer review status:UNDER REVIEW

27 Apr 2020Submitted to Clinical Otolaryngology
28 Apr 2020Assigned to Editor
28 Apr 2020Submission Checks Completed
06 May 2020Reviewer(s) Assigned
07 Jun 2020Review(s) Completed, Editorial Evaluation Pending

Abstract

1. The age range of patients responding to the survey was 28-85 with a mean of 58\(\pm\)12 years with the duration of their disorder less than 5 years in 63% of cases.
2. Patients experience variable treatment, if at all, for post-viral olfactory loss
3. If treatment is given oral and/or intranasal steroids are typically given.
4. Several patients reported receiving imaging despite this not being clinically useful when there is a clear history and normal examination.
5. Over two thirds of patients experience parosmia and up to 5 years of the onset of the problem were still actively seeking a solution.